Guideline for the diagnosis and management of hypertension in adults — 2016

Medical Journal of Australia

Volumn 205, Issue 2, 2016, Pages 85-89

  Gabb, Genevieve M ^a,b   Mangoni, Arduino ^c   Anderson, Craig S ^d,e   Cowley, Diane ^f   Dowden, John S ^g   Golledge, Jonathan ^h   Hankey, Graeme J ⁱ   Howes, Faline S ^j   Leckie, Les ^k   Perkovic, Vlado ^d   Schlaich, Markus ^l   Zwar, Nicholas A ^m   Medley, Tanya L ⁿ   Arnolda, Leonard ^o  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^f PRINCESS ALEXANDRA HOSPITAL   (Australia)

^g Australian Prescriber   (Australia)

^h JAMES COOK UNIVERSITY   (Australia)

ⁱ UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^j UNIVERSITY OF TASMANIA   (Australia)

^k Monash University ^*  (Australia)

^l MONASH UNIVERSITY   (Australia)

^m UNIVERSITY OF NEW SOUTH WALES   (Australia)

ⁿ MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^o UNIVERSITY OF WOLLONGONG   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

ACUTE KIDNEY FAILURE; ADULT; ADVERSE OUTCOME; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; DEATH; DIASTOLIC BLOOD PRESSURE; ELECTROLYTE DISTURBANCE; FAINTNESS; HEART FAILURE; HUMAN; HYPERTENSION; HYPOTENSION; ISCHEMIC HEART DISEASE; MORBIDITY; PRACTICE GUIDELINE; SYSTOLIC BLOOD PRESSURE; ANIMAL; AUSTRALIA; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASES; CLASSIFICATION; DEVICES; FEMALE; MALE; MIDDLE AGED; RISK ASSESSMENT; STROKE;

ADULT; ANIMALS; ANTIHYPERTENSIVE AGENTS; AUSTRALIA; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK ASSESSMENT; STROKE;

EID: 84978719336     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja16.00526     Document Type: Article

References (23)

1. Australian Bureau of Statistics. National Health Survey. First results, 2014 e15. www.abs.gov.au/ausstats/abs@.nsf/mf/4364.0.55.001 (accessed June 2016).
2. Heart Foundation. Cardiovascular disease fact sheet. http://heartfoundation.org.au/about-us/what-we-do/heart-disease-in-australia/cardiovascular-disease-factsheet (accessed May 2016).
3. Stamler J, Rose G, Stamler R, et al. INTERSALT study findings. Public health and medical care implications. Hypertension 1989; 14: 570-577.
4. Verdecchia P, Gentile G, Angeli F, et al. Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials. J Hypertens 2010; 28: 1356-1365.
5. National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee). Guide to management of hypertension 2008: assessing and managing raised blood pressure in adults. Updated December 2010. http://heartfoundation.org.au/forprofessionals/ clinical-information/hypertension (accessed May 2016).
6. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507-520.
7. National Institute of Clinical Excellence (NICE). Hypertension in adults: diagnosis and management 2011. https://www.nice.org.uk/guidance/cg127 (accessed May 2016).
8. European Society of Hypertension and European Society of Cardiology (ESH/ESC). Guidelines for the management of arterial hypertension. Blood Pressure 2013; 22: 193-278.
9. Sackett D, Richardson WS, Rosenburg W, Haynes RB. How to practice and teach evidence based medicine. 2nd ed. Churchill Livingstone, 1997.
10. National Health and Medical Research Council. NHMRC additional levels of evidence and grades for recommendations for developers of guidelines. 2009. https://www.nhmrc.gov.au/_files_nhmrc/file/guidelines/developers/nhmrc_levels_grades_evidence:120423.pdf (accessed Mar 2016).
11. Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926.
12. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-1357.
13. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for onemillion adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
14. NVDPA National Vascular Disease Prevention Alliance. Guidelines for the management of absolute cardiovascular disease risk. Melbourne: National Stroke Foundation, 2012. https://strokefoundation. com.au/what-we-do/treatment-programs/clinicalguidelines/guidelines-for-the-assessment-andmanagement-of-absolute-cvd-risk (accessed May 2016).
15. Bliziotis IA, Destounis A, Stergiou GS. Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis. J Hypertens 2012; 30: 1289-1299.
16. Niiranen TJ, Asayama K, Thijs L, et al. Outcome-driven thresholds for home blood pressure measurement: international database of home blood pressure in relation to cardiovascular outcome. Hypertension 2013; 61:27-34.
17. The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373: 2103-2116
18. Myers MG, Kaczorowski J, Dawes M, Godwin M. Automated office blood pressure measurement in primary care. Can Fam Physician 2014; 60: 127-132
19. British Hypertension Society. BP monitors. www.bhsoc.org/bp-monitors/bp-monitors (accessed Apr 2016).
20. Sundström J, Arima H, Jackson R, et al. Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. Ann Intern Med 2015; 162: 184-191.
21. Blood Pressure Lowering Treatment Trialists’ Collaboration; Sundström J, Arima H, Woodward M, et al. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet 2014; 384: 591-598.
22. Bhatt DL, Kandzari DE, O’Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393-1401.
23. Kidney Disease Improving Global Outcomes. Blood pressure in CKD: KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. http://kdigo.org/home/guidelines/blood-pressure-in-ckd (accessed May 2016).